Studies show combined therapy can improve blood sugar control and metabolic health, but side effects may increase
Emerging technologies to target drug delivery to the skin the role of crystals and carrier-based systems in the case study of Dapsone
Why it did so well: Merck recorded $1.7 billion in revenue from its type 2 diabetes drug Janumet in 2022
Early studies show promising results for alcohol use disorder, with several clinical trials now exploring applications for other substance dependencies
Semaglutide therapy was associated with reduced liver stiffness We analyzed 326 semaglutide-treated patients with available quantitative liver stiffness measurements ( Tables S2-8 ) during the pre-index (at most 5 years before starting semaglutide) and post-index period (at least 6 months and at most 5 years after starting semaglutide)
To evaluate the effect of BPC-157 on intracellular signal transduction, the phosphorylation level of ERK1/2, JNK, and p38 MAPK were examined in HUVECs